Conditions

The answer comes from a mediation analysis of the EMPA-REG OUTCOME Trial.

Young patients with low BMIs, C-peptide levels, and significant symptoms at onset of diabetes at higher risk of undergoing rapid C-peptide decline.

Patients are not seeing the expected results because of medication adherence.

Getting type 2 diabetes at an early age increases risk for all diabetes complications, including death.

How best to decide whether to use one or a combination of the new treatments and individualize the treatment for your patients.

With much of the U.S. in the grip of harsh winter weather as December 2017 comes to a close, we're revisiting a post we originally published in 2013 about how having diabetes or prediabetes can increase the risk of frostbite. The risk was dramatically illustrated by the experience of British explorer Sir Ranulph Fiennes, who had to pull out of a grueling expedition to cross Antarctica due to the effects of frostbite. We wish all our readers a healthy, safe, and warm new year!

Study reports Vitamin D supplementation may improve HbA1c and lower cholesterol.

Identifying causes of death and related risk factors in patients with type 2 diabetes and cardiovascular disease may help with prevention.

Additive glucose-lowering effect of a dipeptidyl peptidase-4 (DPP4) inhibitor and an alpha-glucosidase inhibitor (AGI) might be beneficial in patients with T2DM.

Once-weekly injectable suspension can provide as much benefit as traditional twice-daily dosing.